RaySearch Laboratories AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,292	1,192	1,022	843.65	641.67	651.61
Revenue Growth (YoY)	10.48%	16.62%	21.16%	31.48%	-1.52%	-12.13%
Cost of Revenue	90.99	99.49	106.58	94.99	50.4	43.37
Gross Profit	1,201	1,093	915.58	748.66	591.28	608.24
Selling, General & Admin	646.27	576.17	558.01	481.14	422.23	397.52
Research & Development	271.28	269.38	237.74	238.77	233.44	185.04
Other Operating Expenses	17.98	-4.52	-2.64	-1.56	-0.35	-
Operating Expenses	935.54	841.04	793.1	718.35	655.32	582.56
Operating Income	265	251.5	122.48	30.31	-64.04	25.68
Interest Expense	-8.79	-8.99	-9.69	-11.48	-6.04	-5.75
Interest & Investment Income	11.42	11.42	4.9	1.11	0.71	2.74
Currency Exchange Gain (Loss)	8.99	8.99	-7.6	12.44	10.7	-29.14
Other Non Operating Income (Expenses)	-0.06	-0.06	-0.01	-	-	-
Pretax Income	276.57	262.87	110.09	32.38	-58.67	-6.48
Income Tax Expense	57.35	59.35	28.52	8.6	-11.36	2.6
Net Income	219.21	203.51	81.57	23.78	-47.32	-9.08
Net Income to Common	219.21	203.51	81.57	23.78	-47.32	-9.08
Net Income Growth	25.24%	149.49%	243.06%	-	-	-
Shares Outstanding (Basic)	34	34	34	34	34	34
Shares Outstanding (Diluted)	34	34	34	34	34	34
EPS (Basic)	6.39	5.94	2.38	0.69	-1.38	-0.26
EPS (Diluted)	6.39	5.94	2.38	0.69	-1.38	-0.26
EPS Growth	25.27%	149.49%	244.84%	-	-	-
Free Cash Flow	290.07	471.97	431.64	307.26	186.19	301.8
Free Cash Flow Per Share	8.46	13.77	12.59	8.96	5.43	8.80
Dividend Per Share	3.000	3.000	0.700	-	-	-
Dividend Growth	328.57%	328.57%	-	-	-	-
Gross Margin	92.95%	91.65%	89.57%	88.74%	92.15%	93.34%
Operating Margin	20.52%	21.10%	11.98%	3.59%	-9.98%	3.94%
Profit Margin	16.97%	17.07%	7.98%	2.82%	-7.37%	-1.39%
Free Cash Flow Margin	22.46%	39.59%	42.23%	36.42%	29.02%	46.31%
EBITDA	295.66	286.16	214.52	69.74	-33.24	56.89
EBITDA Margin	22.89%	24.01%	20.99%	8.27%	-5.18%	8.73%
D&A For EBITDA	30.66	34.66	92.05	39.43	30.8	31.21
EBIT	265	251.5	122.48	30.31	-64.04	25.68
EBIT Margin	20.52%	21.10%	11.98%	3.59%	-9.98%	3.94%
Effective Tax Rate	20.74%	22.58%	25.90%	26.55%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.